Document is current
Any future updates will be listed below
-
Authors
Ayati, Aryan
Watanabe, Alexandre H.
Guillot, Jordan
Azzam, Shadera
Zhang, Xiao
Chaudhri, Eirum
Vendetti, Melissa
Fernandes, Gail
Rudrapatna, Vivek A.
Ge, Jin
-
Funding
Funding for this research was provided by:
Merck
- License Information
-
More Information
Article History
Received: 15 September 2025
Accepted: 22 January 2026
First Online: 3 March 2026
Competing interests
: The authors disclose the following. J. Guillot received a postdoctoral fellowship supported by Gilead Sciences. A.W., G.F., X.Z., E.C., and M.V. MSD employees. J. Ge previously served on an advisory board for Gilead Sciences and consulted Astellas Pharmaceuticals/Iota Biosciences and Madrigal Pharmaceuticals. V.R. previously received funding from Janssen, Takeda, Blueprint Medicines, Mitsubishi Tanabe, Genentech, and Stryker, and has a patent pending for ZebraMD.
